NASDAQ: RAPP · Health Care / Biotechnology: Pharmaceutical Preparations

Rapport Therapeutics Inc.

How Rapport Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.2B

Price

$24.21

P/E

-8.5

EPS (TTM)

$-2.86

1-year return

-11.6%

Dividend yield

0.0%

52-week range

$24.21–$33.60

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources